Cargando…

Brexpiprazole Alters Monoaminergic Systems following Repeated Administration: an in Vivo Electrophysiological Study

BACKGROUND: Brexpiprazole was recently approved as adjunctive therapy for depression and treatment of schizophrenia in adults. To complement results from a previous study in which its acute effects were characterized, the present study assessed the effect of repeated brexpiprazole administration on...

Descripción completa

Detalles Bibliográficos
Autores principales: Oosterhof, Chris A., Mansari, Mostafa El, Bundgaard, Christoffer, Blier, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815476/
https://www.ncbi.nlm.nih.gov/pubmed/26428352
http://dx.doi.org/10.1093/ijnp/pyv111
_version_ 1782424596745551872
author Oosterhof, Chris A.
Mansari, Mostafa El
Bundgaard, Christoffer
Blier, Pierre
author_facet Oosterhof, Chris A.
Mansari, Mostafa El
Bundgaard, Christoffer
Blier, Pierre
author_sort Oosterhof, Chris A.
collection PubMed
description BACKGROUND: Brexpiprazole was recently approved as adjunctive therapy for depression and treatment of schizophrenia in adults. To complement results from a previous study in which its acute effects were characterized, the present study assessed the effect of repeated brexpiprazole administration on monoaminergic systems. METHODS: Brexpiprazole (1mg/kg, subcutaneous) or vehicle was administered once daily for 2 and 14 days. Single-unit electrophysiological recordings from noradrenaline neurons in the locus coeruleus, serotonin neurons in the dorsal raphe nucleus, dopaminergic neurons in the ventral tegmental area, and pyramidal neurons in the hippocampus CA3 region were obtained in adult male Sprague-Dawley rats under chloral hydrate anesthesia within 4 hours after final dosing. RESULTS: Brexpiprazole blunted D(2) autoreceptor responsiveness, while firing activity of ventral tegmental area dopaminergic neurons remained unaltered. Brexpiprazole increased the firing rate of locus coeruleus noradrenaline neurons and increased noradrenaline tone on α(2)-adrenergic receptors in the hippocampus. Administration of brexpiprazole for 2 but not 14 days increased the firing rate of serotonin neurons in the dorsal raphe nucleus. In the hippocampus, serotonin(1A) receptor blockade significantly disinhibited pyramidal neurons after 2- and 14-day brexpiprazole administration. In contrast, no significant disinhibition occurred after 24-hour washout or acute brexpiprazole. CONCLUSIONS: Repeated brexpiprazole administration resulted in a marked occupancy of D(2) autoreceptors, while discharge activity of ventral tegmental area dopaminergic neurons remained unaltered. Brexpiprazole enhanced serotonergic and noradrenergic tone in the hippocampus, effects common to antidepressant agents. Together, these results provide further insight in the neural mechanisms by which brexpiprazole exerts antidepressant and antipsychotic effects.
format Online
Article
Text
id pubmed-4815476
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-48154762016-04-04 Brexpiprazole Alters Monoaminergic Systems following Repeated Administration: an in Vivo Electrophysiological Study Oosterhof, Chris A. Mansari, Mostafa El Bundgaard, Christoffer Blier, Pierre Int J Neuropsychopharmacol Research Article BACKGROUND: Brexpiprazole was recently approved as adjunctive therapy for depression and treatment of schizophrenia in adults. To complement results from a previous study in which its acute effects were characterized, the present study assessed the effect of repeated brexpiprazole administration on monoaminergic systems. METHODS: Brexpiprazole (1mg/kg, subcutaneous) or vehicle was administered once daily for 2 and 14 days. Single-unit electrophysiological recordings from noradrenaline neurons in the locus coeruleus, serotonin neurons in the dorsal raphe nucleus, dopaminergic neurons in the ventral tegmental area, and pyramidal neurons in the hippocampus CA3 region were obtained in adult male Sprague-Dawley rats under chloral hydrate anesthesia within 4 hours after final dosing. RESULTS: Brexpiprazole blunted D(2) autoreceptor responsiveness, while firing activity of ventral tegmental area dopaminergic neurons remained unaltered. Brexpiprazole increased the firing rate of locus coeruleus noradrenaline neurons and increased noradrenaline tone on α(2)-adrenergic receptors in the hippocampus. Administration of brexpiprazole for 2 but not 14 days increased the firing rate of serotonin neurons in the dorsal raphe nucleus. In the hippocampus, serotonin(1A) receptor blockade significantly disinhibited pyramidal neurons after 2- and 14-day brexpiprazole administration. In contrast, no significant disinhibition occurred after 24-hour washout or acute brexpiprazole. CONCLUSIONS: Repeated brexpiprazole administration resulted in a marked occupancy of D(2) autoreceptors, while discharge activity of ventral tegmental area dopaminergic neurons remained unaltered. Brexpiprazole enhanced serotonergic and noradrenergic tone in the hippocampus, effects common to antidepressant agents. Together, these results provide further insight in the neural mechanisms by which brexpiprazole exerts antidepressant and antipsychotic effects. Oxford University Press 2015-10-01 /pmc/articles/PMC4815476/ /pubmed/26428352 http://dx.doi.org/10.1093/ijnp/pyv111 Text en © The Author 2015. Published by Oxford University Press on behalf of CINP. http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Research Article
Oosterhof, Chris A.
Mansari, Mostafa El
Bundgaard, Christoffer
Blier, Pierre
Brexpiprazole Alters Monoaminergic Systems following Repeated Administration: an in Vivo Electrophysiological Study
title Brexpiprazole Alters Monoaminergic Systems following Repeated Administration: an in Vivo Electrophysiological Study
title_full Brexpiprazole Alters Monoaminergic Systems following Repeated Administration: an in Vivo Electrophysiological Study
title_fullStr Brexpiprazole Alters Monoaminergic Systems following Repeated Administration: an in Vivo Electrophysiological Study
title_full_unstemmed Brexpiprazole Alters Monoaminergic Systems following Repeated Administration: an in Vivo Electrophysiological Study
title_short Brexpiprazole Alters Monoaminergic Systems following Repeated Administration: an in Vivo Electrophysiological Study
title_sort brexpiprazole alters monoaminergic systems following repeated administration: an in vivo electrophysiological study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815476/
https://www.ncbi.nlm.nih.gov/pubmed/26428352
http://dx.doi.org/10.1093/ijnp/pyv111
work_keys_str_mv AT oosterhofchrisa brexpiprazolealtersmonoaminergicsystemsfollowingrepeatedadministrationaninvivoelectrophysiologicalstudy
AT mansarimostafael brexpiprazolealtersmonoaminergicsystemsfollowingrepeatedadministrationaninvivoelectrophysiologicalstudy
AT bundgaardchristoffer brexpiprazolealtersmonoaminergicsystemsfollowingrepeatedadministrationaninvivoelectrophysiologicalstudy
AT blierpierre brexpiprazolealtersmonoaminergicsystemsfollowingrepeatedadministrationaninvivoelectrophysiologicalstudy